These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4262607)

  • 21. [Effectiveness of streptokinase preparations in experimental deep venous thrombosis].
    Bogomolova LG; Dembo MA; Osipov SN
    Probl Gematol Pereliv Krovi; 1973 Dec; 18(12):13-7. PubMed ID: 4789364
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of acute arterial and venous obstructions].
    Nicolosi G
    Recenti Prog Med; 1970 Jun; 48(6):503-28. PubMed ID: 5536682
    [No Abstract]   [Full Text] [Related]  

  • 23. Acyl-enzymes as thrombolytic agents in a rabbit model of venous thrombosis.
    Smith RA; Dupe RJ; English PD; Green J
    Thromb Haemost; 1982 Jun; 47(3):269-74. PubMed ID: 6214039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinolysis and its current usage.
    Rubin RN
    Clin Ther; 1983; 5(3):211-22. PubMed ID: 6342782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The diagnosis, treatment and prevention of thromboembolism of the pulmonary artery in a general hospital].
    Ukolov VM; Rakov AL; Krashutskiĭ VV; Proskurin VM; Shepilov VV
    Voen Med Zh; 1995 Oct; (10):34-8. PubMed ID: 8533359
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined thrombolytic and Dotter treatment in arterial occlusive disease.
    Eie H; Ro J; Amundsen E; Osvik K
    J Oslo City Hosp; 1972; 22(9):141-8. PubMed ID: 5075930
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombolytic therapy: an introduction and review.
    Thiagarajan D
    J Kans Med Soc; 1980 Jun; 81(6):292-3. PubMed ID: 6995538
    [No Abstract]   [Full Text] [Related]  

  • 28. [Development and results of thrombolytic therapy].
    Deutsch E; Ebringer H; Lechner K; Pilgerstorfer HW
    Wien Med Wochenschr; 1971 May; 121(20):410-5. PubMed ID: 5566996
    [No Abstract]   [Full Text] [Related]  

  • 29. A thrombosis model for evaluating thrombolytic agents in the guinea-pig: comparison of t-PA, scu-PA and a novel thrombolytic agent, staphylokinase, on thrombolytic activity.
    Hirata Y; Umemura K; Takiguchi Y; Uematsu T; Nakashima M
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):569-75. PubMed ID: 7692999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical use of thrombolytic agents].
    Laprevote-Heully MC; Lambert H; Larcan A
    Agressologie; 1983 Nov; 24(11):559-65. PubMed ID: 6367511
    [No Abstract]   [Full Text] [Related]  

  • 31. [Acute pulmonary thromboembolism with severe hemodynamic compromise. The efficacy of systemic thrombolytic treatment in the coronary unit].
    Martínez Martínez J; Irazola V; Nohara W; Alberto Sampó E
    Rev Esp Cardiol; 1994 Nov; 47(11):773-6. PubMed ID: 7800909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic indications in acute arterial obstruction of the extremities].
    Vaysse J; Maillet R; Allary M
    Rev Atheroscler (Paris); 1968; 10(2):37-46. PubMed ID: 5759949
    [No Abstract]   [Full Text] [Related]  

  • 33. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 34. Special problems in the use of heparin for thromboembolism.
    Lewis MR; Dale WA
    Surg Gynecol Obstet; 1973 Sep; 137(3):472-4. PubMed ID: 4721521
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical observations in thromboembolic disease treated with fibrinolysin.
    MOSER KM
    Angiology; 1959 Aug; 10():319-31. PubMed ID: 14424538
    [No Abstract]   [Full Text] [Related]  

  • 36. Controlled multicenter pilot study of urokinase- heparin and streptokinase in deep vein thrombosis.
    van de Loo JC; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Asbeck F; Marbet GA; Schmitt HE; Sewell AF; Duckert F
    Thromb Haemost; 1983 Oct; 50(3):660-3. PubMed ID: 6359570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [EXPERIENCE WITH THE TREATMENT OF THROMBOSIS AND EMBOLISM WITH FIBRINOLYSIN AND HEPARIN].
    GEFTER AI; PONOMAREVA AG; ANDREENKO GV
    Ter Arkh; 1964 Dec; 36():24-9. PubMed ID: 14325708
    [No Abstract]   [Full Text] [Related]  

  • 38. Rationale of heparin in the treatment of thromboembolic disease.
    LOEWE L
    Interne; 1947 Nov; 13(11):493; passim. PubMed ID: 18897566
    [No Abstract]   [Full Text] [Related]  

  • 39. Proper management of thromboembolic disease.
    Spartalis MA
    J Natl Med Assoc; 1996 Mar; 88(3):137; 150; 157. PubMed ID: 8839027
    [No Abstract]   [Full Text] [Related]  

  • 40. FIBRINOLYSIN for treatment of blood-clots in man.
    Lancet; 1958 Sep; 2(7047):624-5. PubMed ID: 13588952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.